ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

Polymer Platinate Begins Testing In Phase I Trial.

September 29, 2000

Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”

June 17, 2011

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University.

March 11, 2005

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999

NABCO to close June 30.

January 30, 2004